M&A Insider



Rumor News

  • [11/28, 1:28 PM]
  • [11/28, 1:26 PM]
  • [11/28, 12:48 PM]
  • [11/28, 10:38 AM]
  • [11/28, 8:05 AM]
  • See More

Merger Arbitrage

Company Ticker Acquirer Announced Date Deal Price Current Price Spread Expected Close
Allergan AGN Actavis plc 11/17/2014 $228.89 $213.89 7% 6/30/2015
Baker Hughes BHI Halliburton 11/17/2014 $66.26 $57.00 16.3% 12/31/2015
ChyronHego CHYR Vector Capital 11/17/2014 $2.82 $2.80 0.7% 3/31/2015
Cimatron Ltd. CIMT 3D Systems 11/24/2014 $8.97 $8.67 3.5% 3/31/2015
Hampden Bancorp HBNK Berkshire Hills Bancorp 11/4/2014 $20.56 $20.08 2.4% 6/30/2015
Oplink Communications OPLK Koch Industries 11/19/2014 $24.25 $24.17 0.3% N/A
Platinum Underwriters PTP RenaissanceRe 11/24/2014 $73.69 $74.17 -0.7% 6/30/2015
Prosensa RNA BioMarin Pharma 11/24/2014 $0.00 $19.77 -100% 3/31/2015
Susquehanna Bancshares SUSQ BB&T 11/12/2014 $13.56 $13.17 3% N/A
Valley Financial VYFC BNC Bancorp 11/17/2014 $20.50 $19.80 3.5% 6/30/2015


Highlighted Deal

On February 14, H.J. Heinz Co. (NYSE: HNZ) confirmed a deal to be acquired by Warren Buffett's Berkshire Hathaway (NYSE: BRK-A) (NYSE: BRK-B) and 3G Capital for $72.50 per share in cash or $28 billion.

The per share price represents a 20% premium to Heinz’s closing share price of $60.48 on February 13, 2013, a 19% premium to Heinz’s all-time high share price, a 23% premium to the 90-day average Heinz share price and a... CONTINUE